Caribbean Center for Clinical Research

Guaynabo 00968

1 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy — Recruiting now